CytoMed Therapeutics Limited

GDTCNASDAQHealthcare● Active

$1.15

$-0.14(-10.85%)

Market Cap$13607760

P/E Ratio—

52W High$3.68

52W Low$0.68

Avg Volume14K

Open$1.14

Beta-0.04

Cash on Hand Financials Revenue

CytoMed Therapeutics Limited (GDTC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GDTC · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$2.1M▼ -57.8% vs prior year

FY · as of Dec 31, 2025 · Reported in SGD

Cash & Cash Equiv. (CCE)

$2.1M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-57.8%

vs prior fiscal year

Latest Quarter

$2.1M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SGD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$2.1MCash on Hand

Total Debt$482,562Total Debt

Net Cash / Net Debt+$1.6MNet Cash Position

Cash vs Debt Ratio

Cash 81%CytoMed Therapeutics Limited cash as % of market cap: 15.40%% · MCap $0BDebt 19%

CytoMed Therapeutics Limited has a net cash position of $1.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$2.1M − $482,562 = +$1.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GDTC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GDTC cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$2.1M-57.8%

Dec 31, 2024FY$5.0M-44.9%

Dec 31, 2023FY$9.0M+468.3%

Dec 31, 2022FY$1.6M-37.4%

Dec 31, 2021FY$2.5M+172.2%

GDTC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GDTC vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

CytoMed Therapeutics LimitedYOU

GDTC

$2.1M$14M15.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

CytoMed Therapeutics Limited (GDTC) cash on hand as of December 31, 2025 is $2.1M, comprising $2.1M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as CytoMed Therapeutics Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as CytoMed Therapeutics Limited cash reserves or cash position.

CytoMed Therapeutics Limited annual cash on hand history shows decreased -57.8% in 2025: decreased -57.8% in 2025. CytoMed Therapeutics Limited cash reserves in 2025 reflect the company's capital allocation strategy.

CytoMed Therapeutics Limited carries total debt of $482,562 against cash of $2.1M, resulting in a net cash position of +$1.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GDTC cash on hand · 5 questions

As of December 31, 2025, CytoMed Therapeutics Limited (GDTC) has $2,095,489 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2,095,489 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $2,095,489. Data sourced from the annual 10-K filing via FMP.

GDTC cash on handGDTC cash reservesGDTC cash 2025how much cash does GDTC have

▸ Source: FMP /balance-sheet-statement · US GAAP · CytoMed Therapeutics Limited · CytoMed Therapeutics Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025